Search results for "Formula"

showing 10 items of 755 documents

OHP-041 Formulary Decision-Making For Biosimilars: Considerations For Hospital Pharmacists

2013

Background It has been 6 years since the first biosimilar was approved for use in the European Union (EU). Given the likelihood that biosimilar monoclonal antibodies will be approved in Europe in the near future, it is timely to review the formulary selection criteria for biologicals and biosimilars. The European Medicines Agency (EMA) has issued guidelines that define the regulation of biosimilars in Europe and recommend approaches to establish biosimilarity. However, several questions regarding the assessment of biosimilars for formulary inclusion remain unanswered, including those related to manufacturing and drug supply. Purpose To aid hospital pharmacists in developing evaluation crite…

Actuarial sciencebusiness.industrySupply chainmedia_common.quotation_subjectBiosimilarHealth caremedia_common.cataloged_instanceMedicineQuality (business)Product (category theory)Supply chain securityGeneral Pharmacology Toxicology and PharmaceuticsFormularyEuropean unionbusinessmedia_commonEuropean Journal of Hospital Pharmacy
researchProduct

Leukocyte migration test (LMT) in patients with thyroid disease: the response to human thyroid subcellular fractions.

1981

The response of circulating leukocytes to thyroid subcellular fractions was investigated in 19 patients with Graves' disease, 15 patients with Hashimoto's thyroiditis, 7 patients with toxic adenoma, 19 patients with nontoxic goiter and in 10 healthy students as control subjects. For this purpose, the leukocyte migration test of Soborg and Bendixen was performed against human crude thyroid extract (CTE), cell plasma membranes, nuclei, ribosomes, mitochondria and microsomes. Our results show positive LMT against: 1) CTE in patients with Graves' disease (61 +/- 13, p less than 0.001) and Hashimoto's thyroiditis (65 +/- 11, p less than 0.001) compared to controls (90 +/- 11); 2) cell plasma mem…

AdenomaAdultMaleendocrine systemmedicine.medical_specialtyLeukocyte migrationendocrine system diseasesAdolescentEndocrinology Diabetes and MetabolismCellThyroid GlandThyroiditisEndocrinologyInternal medicinemedicineLeukocytesHumansIn patientbusiness.industryGoiterThyroid diseaseThyroidThyroiditis AutoimmuneMiddle Agedmedicine.diseaseThyroid DiseasesGraves Diseasemedicine.drug_formulation_ingredientmedicine.anatomical_structureEndocrinologyCell Migration InhibitionMicrosomeFemalebusinessThyroid extractSubcellular FractionsJournal of endocrinological investigation
researchProduct

Evaluation of Sialic Acid in Infant Feeding: Contents and Bioavailability

2016

Sialic acid (Sia) contents and bioaccessibility (BA) in human milk (HM) and infant formulas (IFs) were determined, and Sia intakes by infants between 0 and 6 months of age were evaluated. Total Sia contents in HM decreased during lactation from 136.14 to 24.47 mg/100 mL. The total Sia contents in IFs (13.15-25.78 mg/100 mL) were lower than in HM and were not related to the addition of ingredients acting as sources of Sia in their formulation. The Sia intakes derived from IF consumption were lower than in HM, and only one IF reached the intakes provided by HM from the age of 2 months. Despite the lower total Sia content in IFs, the BA of Sia in IFs (88.08-92.96%) was significantly greater th…

AdultAdolescentBiological Availability01 natural sciencesYoung Adultchemistry.chemical_compound0404 agricultural biotechnologyLactationmedicineHumansFood scienceInfant feedingMilk Human010401 analytical chemistry04 agricultural and veterinary sciencesGeneral Chemistry040401 food scienceInfant FormulaN-Acetylneuraminic AcidBottle Feeding0104 chemical sciencesSialic acidBioavailabilityBreast Feedingmedicine.anatomical_structurechemistryColostrumFemaleNeuraminic AcidsGeneral Agricultural and Biological SciencesJournal of Agricultural and Food Chemistry
researchProduct

Somatostatin-receptor scintigraphy in Graves' disease: reproducibility and variance of orbital activity.

2000

Somatostatin-receptor (SSTR) scintigraphy using the single photon emission computed tomography (SPECT) technique allows the assessment of orbital inflammation in patients with Graves' disease. Previous studies showed differences in orbital octreotide uptake already 4 hr after injection. In this study, analysis of inter-/intra-observer variance and reproducibility in the evaluation of orbital SPECT images was performed. First, SPECT data of one representative female patient with clinically active Graves' ophthalmopathy (GO), obtained 4 hr after intravenous injection of 110 MBq 111In-pentetreotide and processed by filtered backprojection, were analyzed. Transverse SPECT images were reconstruc…

AdultMaleCancer ResearchGraves' diseaseSingle-photon emission computed tomographyScintigraphyCorrelationSpearman–Brown prediction formulamedicineHumansRadiology Nuclear Medicine and imagingAgedPharmacologyObserver VariationTomography Emission-Computed Single-PhotonReproducibilitymedicine.diagnostic_testbusiness.industryIndium RadioisotopesReproducibility of ResultsGeneral MedicineVariance (accounting)Middle Agedmedicine.diseaseGraves DiseaseOncologyFemaleTomographybusinessNuclear medicineSomatostatinOrbitCancer biotherapyradiopharmaceuticals
researchProduct

Breastfeeding and experience with variety early in weaning increase infants' acceptance of new foods for up to two months.

2008

International audience; BACKGROUND & AIMS: Previous studies showed that (1) breastfeeding and (2) higher food variety early in weaning can increase acceptance of new foods for the next few days. Here we measure, in two European regions, effects of breast or formula feeding and experience with different levels of vegetable variety early in weaning on new food acceptance during two months following the start of weaning. METHODS: Breast- or formula-fed infants received their first vegetable (carrot pur? and, over the next 9 days, either carrots every day; 3 vegetables changed every 3 days; or 3 vegetables changed daily. On the 12th and 23rd days they received new vegetable pur?, zucchini-tomat…

AdultMalePediatricsmedicine.medical_specialtyFood intake030309 nutrition & dieteticsBreastfeedingMothersCritical Care and Intensive Care Medicine03 medical and health sciencesFood Preferences0302 clinical medicineAnimal scienceFormula feedingFOOD ACCEPTANCEVegetablesFLAVOUR VARIETYWeaningMedicineHumans030212 general & internal medicine2. Zero hunger0303 health sciencesNutrition and Dieteticsbusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceBREASTFEEDINGfood and beveragesFood acceptanceInfantCOMPLEMENTARY FEEDINGInfant FormulaBreast FeedingInfant formula[ SCCO.NEUR ] Cognitive science/NeuroscienceFish <Actinopterygii>FemaleInfant FoodbusinessBreast feedingClinical nutrition (Edinburgh, Scotland)
researchProduct

Gastrointestinal symptoms in infancy: A population-based prospective study

2005

Abstract Background. During the first months of life, infants can suffer from many ‘minor’ gastroenterological disturbances. However, little is known about the frequency of these problems and the factors which predispose or facilitate their onset. Aims. (a) To ascertain the frequency of the most common gastrointestinal symptoms in infants during the first 6 months after birth; (b) to evaluate the influence of some variables on the onset of the symptoms. Study design and patients. Each of the 150 paediatricians distributed throughout Italy followed 20 consecutive infants from birth to 6 months. 2879 infants (1422 f, 1457 m) concluded the study. The presence of the following symptoms was eval…

AdultMalecolic; constipation; diarrhoea; epidemiology; failure to thrive; feeding; infancy; regurgitation; vomitingPediatricsmedicine.medical_specialtyInfancySettore MED/09 - Medicina InternaConstipationColicEpidemiologyVomitingGestational AgemedicineHumansProspective StudiesProspective cohort studyHepatologybusiness.industryCryingFeedingInfant NewbornGastroenterologyInfantGestational ageFailure to thriveRegurgitationInfant Low Birth WeightInfant FormulaDiarrhoeaHospitalizationLow birth weightDiarrheaBreast FeedingItalyDiarrhea InfantileFailure to thriveGastroesophageal RefluxVomitingFemalemedicine.symptombusinessConstipationFollow-Up StudiesDigestive and Liver Disease
researchProduct

Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.

1991

International audience; To determine whether an elemental diet or a polymeric defined formula diet would be more effective for treating active Crohn's disease, we conducted a prospective randomised clinical trial in 30 patients with active Crohn's disease unresponsive to steroids and/or complicated by malnutrition. They received a four to six week enteral nutrition course with either an elemental diet or a polymeric diet. Clinical remission occurred in 10 of the 15 patients on elemental diet compared with 11 of the 15 patients assigned to polymeric diet. Both groups showed similar improvements in nutritional status, biological inflammation, alpha 1 antitrypsin clearance, and colonoscopic le…

AdultMalemedicine.medical_specialtyElemental dietColon030309 nutrition & dieteticsNutritional StatusEnteral administrationGastroenterologylaw.invention03 medical and health sciencesEnteral Nutrition0302 clinical medicineCrohn DiseaseRandomized controlled trial[ CHIM.ORGA ] Chemical Sciences/Organic chemistrylawInternal medicinemedicineHumansProspective StudiesProspective cohort studyFood Formulated2. Zero hunger0303 health sciencesCrohn's disease[CHIM.ORGA]Chemical Sciences/Organic chemistrybusiness.industryGastroenterologyColonoscopymedicine.disease[CHIM.ORGA] Chemical Sciences/Organic chemistry3. Good healthClinical trialMalnutritionParenteral nutritionFemale030211 gastroenterology & hepatologybusinessResearch ArticleFollow-Up Studies
researchProduct

Perinatal and newborn care in a two years retrospective study in a first level peripheral hospital in Sicily (Italy)

2019

Abstract Background Two hundred seventy-five thousand maternal deaths, 2.7 million neonatal deaths, and 2.6 million stillbirths have been estimated in 2015 worldwide, almost all in low-income countries (LICs). Moreover, more than 20 million severe disabilities result from the complications of pregnancy, childbirth or its management each year. A significant decrease of mortality/morbidity rates could be achieved by providing effective perinatal and newborn care also in high-income countries (HICs), especially in peripheral hospitals and/or rural areas, where the number of childbirths per year is often under the minimal threshold recognized by the reference legislation. We report on a 2 years…

AdultPatient Transfermedicine.medical_specialtyComplications of pregnancyAdolescentTerm BirthCohort StudiesYoung Adult03 medical and health sciences0302 clinical medicinePregnancyHealth caremedicineHumansChildbirth030212 general & internal medicineRetrospective StudiesPerinatal mortalityPregnancy030219 obstetrics & reproductive medicinebusiness.industryObstetricsResearchPublic healthInfant NewbornQuality of carelcsh:RJ1-570Gestational agelcsh:PediatricsRetrospective cohort studyMiddle AgedStillbirthDelivery ObstetricNewbornmedicine.diseaseInfant FormulaObstetric Labor ComplicationsPerinatal CareBreast FeedingItalyPremature BirthFemaleMaternal deathbusinessItalian Journal of Pediatrics
researchProduct

Targeted Hybrid Nanocarriers as a System Enhancing the Skin Structure

2021

The skin is constantly exposed to external and internal factors that disturb its function. In this work, two nanosystems-levan nanoparticles and a surfactin-stabilized nanoemulsion were preserved (tested for microbial growth) and characterized (size, polydispersity, Zeta potential, and stability). The nanosystems were introduced in the model formulations-cream, tonic, and gel, and confirmed by TEM. The analysis showed that nanoemulsion has a spherical morphology and size 220–300 nm, while levan nanoparticles had irregular shapes independently of the use of matrix and with particle size (130–260 nm). Additionally, we examined the antiradical effect of levan nanoparticles and nanoemulsion in …

AdultskinMaterials scienceDPPHDispersitySkin CreamnanoemulsionPharmaceutical ScienceNanoparticleformulationMicrobial Sensitivity Tests02 engineering and technology030226 pharmacology & pharmacySkin DiscolorationsurfactinArticleAnalytical Chemistrylcsh:QD241-44103 medical and health scienceschemistry.chemical_compound0302 clinical medicinelcsh:Organic chemistryIn vivoDrug DiscoveryZeta potentialHumansPhysical and Theoretical ChemistryDrug CarriersBacteriaanti-agingOrganic ChemistryMiddle Aged021001 nanoscience & nanotechnologyDynamic Light ScatteringlevanFructansSkin AgingchemistryChemistry (miscellaneous)Molecular MedicineEmulsionsFemalenanoparticlesParticle sizeNanocarriers0210 nano-technologyBiomedical engineeringMolecules
researchProduct

Recent aflatoxin survey data in milk and milk products: A review

2017

Aflatoxin M1 (AFM1) occurrence in human and animal milk, infant formula, powdered milk, cheese and yoghurt represents a risk for health. The last four years (2010–2014) of data, as well as the most frequently and updated analytical methods applied for AFM1 quantification, are evaluated. Aflatoxin B1, considered the most potent toxic aflatoxin, is metabolised to form the monohydroxy derivative AFM1. This metabolized, expressed in the milk, is relatively stable, and it is not eliminated by heat treatments or pasteurisation, and thus represents a serious health concern.

AflatoxinChemistryProcess Chemistry and Technology010401 analytical chemistryfood and beveragesPasteurizationBioengineering04 agricultural and veterinary sciences040401 food science01 natural sciences0104 chemical scienceslaw.invention0404 agricultural biotechnologyMilk productsInfant formulalawFood scienceAflatoxins Food Analysis Contamination Levels Milk.Food ScienceInternational Journal of Dairy Technology
researchProduct